Vertaling van "costs of interventions " (Frans → Nederlands) :

TERMINOLOGIE

intervention | intervention
interventie | ingreep

complications dues à un appareillage médical incidents survenus au patient au cours d'actes médicaux et chirurgicaux substance médicamenteuse appropriée et correctement administrée à dose thérapeutique ou prophylactique, mais cause d'un effet indésirable quelconque réactions anormales de patients ou complications tardives causées par des interventions médicales et chirurgicales, sans mention d'incident au cours de l'intervention
complicaties van medische hulpmiddelen | genees- en heelkundige verrichtingen als oorzaak van afwijkende reactie van patiënt, of van latere complicatie, zonder vermelding van afwijkende gang van zaken tijdens verrichting | juist geneesmiddel op juiste wijze toegediend in therapeutische of profylactische dosering als oorzaak van elk ongewenst gevolg | ongelukken met patiënten tijdens genees- en heelkundige behandeling

préopératoire | qui précède une intervention chirurgicale
preoperatief | voor de ingreep

prémédication | traitement préalable à une intervention (médicale ou chirurgicale)
premedicatie | toediening van geneesmiddelen ter voorbereiding van de patiënt

intervention chirurgicale du diaphragme
diafragmaoperatie

intervention chirurgicale du sein
borstoperatie

enseignement sur une intervention
educatieprocedure

intervention chirurgicale d'un os
botoperatie

kit d’intervention chirurgicale ORL avec médicament
set voor chirurgische nko-procedure met medicatie

kit à usage unique d'intervention chirurgicale cardiothoracique avec substances médicamenteuses
set met medicatie voor eenmalig gebruik voor cardiothoracale operatie

IN-CONTEXT TRANSLATIONS

Unit cost: €2.53 Costs of interventions in current practice based on Dutch empirical data Cost calculations of interventions in increased implementation program based on Dutch practice guidelines and (for the duration of NRT and Buproprion) on international trials (Cochrane meta-analysis) Costs of smoking-related diseases were taken into account, estimates based on Dutch cost-ofillness study that allocated total direct health care costs to diseases.
Unit cost: €2.53 Costs of interventions in current practice based on Dutch empirical data Cost calculations of interventions in increased implementation program based on Dutch practice guidelines and (for the duration of NRT and bupropion) on international trials (Cochrane meta-analysis) Costs of smoking-related diseases were taken into account, estimates based on Dutch cost-ofillness study that allocated total direct health care costs to diseases.

Dans les cas où une intervention débouche sur des résultats plus favorables pour la santé mais à un coût supérieur en comparaison avec la meilleure intervention alternative visant la même affection, un rapport coût-efficacité différentiel (Incremental Cost-Effectiveness Ratio, ICER) est calculé.
Wanneer een interventie betere resultaten voor de gezondheid oplevert maar meer kost, kan de kosteneffectiviteit berekend worden, uitgedrukt als een Incremental Cost-Effectiveness Ratio (ICER).

[4] KCE Rapport 178 (31.05.2012) : “Manual for cost-based pricing of hospital interventions”
[4] KCE Rapport 178 (31.05.2012): “Manual for cost-based pricing of hospital interventions”.

Les formulaires pour une demande d'intervention sont disponibles sur [http ...]
Aanvraagformulieren hiervoor zijn te vinden op [http ...]

Cost of Buproprion was not included as this was not reimbursed by the HMO in the context of this intervention.
Cost of bupropion was not included as this was not reimbursed by the HMO in the context of this intervention.

2000 US$ Average retail price of NRT gum (12-week course): US$218.78 Average retail price of NRT patch (8-week course): US$154.36 Average retail price of Buproprion (8-week course): US$201.39 Pharmacist time (5 hours of intervention, US$35/hr): US$175 Technician support (2 hours, US$5/hr): US$10 Material costs: US$5 0%
2000 US$ Average retail price of NRT gum (12-week course): US$218.78 Average retail price of NRT patch (8-week course): US$154.36 Average retail price of bupropion (8-week course): US$201.39 Pharmacist time (5 hours of intervention, US$35/hr): US$175 Technician support (2 hours, US$5/hr): US$10 Material costs: US$5 0%

Odds ratio of NRT versus control: 1.67 Odds ratio of Buproprion versus control: 2.1 Odds ratio of NRT+Buproprion versus control: 2.65 From these Odds Ratios and information on the control 12-month quit rate in the comparator intervention (0.04 for brief advice and 0.10 for counselling), the 12-month quit rate of treatment is calculated: treated quit rate for brief advice+NRT: 0.0650 treated quit rate for brief advice+Buproprion: 0.0805 treated quit rate for brief advice+Buproprion+NRT: 0.0994 treated quit rate for counselling+NRT: 0.1565 treated quit rate for counselling+Buproprion: 0.1892 treated quit rate for counselling+Buproprion+NRT: 0.2275 spontaneous cessation rate: 0.01. lifetime relapse rate: 40% (range 30-50%). number of LYG per quitter: 2 (range 1-3). number of QALYs gained per quitter: 2.7 (range 1.35-4.05) not reported The table gives an overview of the assumptions with respect to costs and effects (quit rates) in the average scenario.
Odds ratio of NRT versus control: 1.67 Odds ratio of bupropion versus control: 2.1 Odds ratio of NRT+bupropion versus control: 2.65 From these Odds Ratios and information on the control 12-month quit rate in the comparator intervention (0.04 for brief advice and 0.10 for counselling), the 12-month quit rate of treatment is calculated: treated quit rate for brief advice+NRT: 0.0650 treated quit rate for brief advice+bupropion: 0.0805 treated quit rate for brief advice+bupropion+NRT: 0.0994 treated quit rate for counselling+NRT: 0.1565 treated quit rate for counselling+bupropion: 0.1892 treated quit rate for counselling+bupropion+NRT: 0.2275 spontaneous cessation rate: 0.01. lifetime relapse rate: 40% (range 30-50%). number of LYG per quitter: 2 (range 1-3). number of QALYs gained per quitter: 2.7 (range 1.35-4.05) not reported The table gives an overview of the assumptions with respect to costs and effects (quit rates) in the average scenario.